Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial
Titel:
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial
Auteur:
Paz-Ares, Luis Borghaei, Hossein Liu, Stephen V Peters, Solange Herbst, Roy S Stencel, Katarzyna Majem, Margarita Şendur, Mehmet Ali Nahit Czyżewicz, Grzegorz Caro, Reyes Bernabé Lee, Ki Hyeong Johnson, Melissa L Karadurmuş, Nuri Grohé, Christian Baka, Sofia Csőszi, Tibor Ahn, Jin Seok Califano, Raffaele Yang, Tsung-Ying Kemal, Yasemin Ballinger, Marcus Cuchelkar, Vaikunth Graupner, Vilma Lin, Ya-Chen Chakrabarti, Debasis Bhatt, Kamalnayan Cai, George Iannone, Robert Reck, Martin